The largest database of trusted experimental protocols

Mla 55

Manufactured by Beckman Coulter
Sourced in United States

The MLA-55 is a fully automated coagulation analyzer designed for in-vitro diagnostic testing. It measures various coagulation parameters to assist in the diagnosis and monitoring of coagulation disorders.

Automatically generated - may contain errors

3 protocols using mla 55

1

Extracellular Vesicle Isolation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For sEV isolation, cells were incubated for 72 h. Then, medium was collected and the cells and cellular debris were removed from the medium by subsequent centrifugation at 300× g for 10 min and 2000× g for 10 min, respectively. The medium was passed through a 0.22 μm-pore-size filter (cellulose acetate membrane, Corning) to remove larger vesicles. The sample was concentrated (Amicon® Ultra, with Ultracel-100 regenerated cellulose membrane; Merck, St. Louis, MO, USA) and ultracentrifuged on 2 mL of 20% sucrose cushion for 135 min, 4 °C at 100,000× g (MLA-55; Beckman Coulter) [72 (link)]. The pellet was resuspended in PBS and subsequently used for nanoparticle-tracking analysis (NTA), transmission electron microscopy, in radioimmunoprecipitation assay buffer (RIPA) for Western blot, and in lysis buffer (mirVana; ThermoFisher) for RNA extraction studies.
+ Open protocol
+ Expand
2

EV Enrichment and Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
One mL of plasma was diluted with 8.5 mL particle-free Dulbecco’s Phosphate buffer saline (dPBS, Sigma-Aldrich, USA), carefully overlaid on 2 mL of 20% sucrose cushion (sucrose (Merck Millipore, USA) in dPBS) in polypropylene tubes (Beckman Coulter, USA) and centrifuged at 100,000×g for 135 min at 4 °C (MLA-55, Beckman Coulter, USA) to enrich EVs in the sample. The supernatant was gently aspirated and residual moisture absorbed from the walls of the tubes. The pellet was resuspended in small volume of dPBS (NTA: 20 µL, AF4-UV-MALS: 40 µL, TEM: 20 µL) and stored at − 20 °C. For miRNA extraction, pellet was resuspended in 200 µL of dPBS and 800 µL Tri-reagent (Sigma, USA) was added before storage.
To analyze repeatability of sUC EV-enrichment method linked to quantification methods, 4 aliquots of plasma from the same donor were processed as described above. Repeatability is measured by % relative standard deviation (%RSD) and is calculated as: (standard deviation/mean)*100.
+ Open protocol
+ Expand
3

Lentiviral Particle Production in HEK293T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Each 106 HEK293T cells were grown in DMEM with 10% FCS and each 1% Penicillin and Streptomycin (Life Technologies, Darmstadt, Germany) at 37 °C, 5% CO2. On the day of transfection, fresh DMEM with 25 μM chloroquine was applied and cells further incubated for 2–6 h. When cells had grown to 80% confluence, transfection was done using the calcium phosphate method, with a final concentration of 0.125 M CaCl2, 3 μg of pMD2. G, 5 μg of pRSV-Rev, 5 μg of pMDLg/pRRE and 10 μg of the respective pLL transfer vector. After overnight incubation, cells were further grown with fresh DMEM, 10% FCS and each 1% Penicillin and Streptomycin. Supernatant was collected on the following 2 days, filtered with a 0.45 μm syringe filter (Corning, Germany) and concentrated by ultracentrifugation for 2 h at 50.000 g (MLA-55, Beckman Coulter). Pellets were re-suspended in PBS and stored at −80 °C. Viral titer was determined using the QuickTiter Lentivirus Titer Kit (Cell Biolabs, USA) according to the manufacturer’s instructions. Experimental vectors (HA-CREB, HA-CREBS133A, shChrm1) were always prepared in parallel with the corresponding control vectors.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!